![DENTSPLY SIRONA Inc. Image](https://thebrios.com/wp-content/uploads/2022/06/dentsply-sirona-inc-300x228.jpg)
Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Investigation
11/27/2020
Initial Lawsuit
12/11/2020
Lawsuit Progression
04/20/2021
Investigation regarding statements made by Kandi about its revenues generated by its two subsidiaries (electric vehicles and smart batteries) and ties to potentially undisclosed related parties.
11/27/2020
Hindenburg Research, after initiating a short-seller position, publishes a report pointing out the history of fraud, alleging fraudulent sales (undisclosed related parties), the failure to launch in the U.S. for the last 12 years and the failed ridesharing and battery swap initiatives.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$13.62 | $14.5 | $-0.88 | -6.07% |
Plaintiff brings this securities class action on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Kandi securities between March 15, 2019 and November 27, 2020, both dates inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) Kandi artificially inflated its reported revenues through undisclosed related party transactions, or otherwise had relationships with key customers that indicated those customers did not have an arms length relationship with Kandi;
(ii) the majority of Kandi’s sales in the past year had been to undisclosed related parties and/or parties with such a close relationship and history with Kandi that it cast doubt on the arms-length nature of their relationship;
(iii) all the foregoing, once revealed, was foreseeably likely to cast doubt on the validity of Kandi’s reported revenues and, in turn, have a foreseeable negative impact on the Company’s reputation and valuation; and
(iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
04/20/2021
The court issued an order appointing the lead plaintiff and lead counsel.
08/27/2021
This is a federal securities class action on behalf of a class consisting of all persons and entities other than Defendants, who purchased or otherwise acquired Kandi stock between March 15, 2019 and November 27, 2020, both dates inclusive.
Operative complaint
02/25/2022
A motion to dismiss was filed with the court.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.